Citation Impact
Citing Papers
Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association
2016
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
Triple-negative breast cancer molecular subtyping and treatment progress
2020 Standout
Evaluation and Management of Patients With Heart Disease and Cancer: Cardio-Oncology
2014
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
2012 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
Cancer Therapy-Induced Left Ventricular Dysfunction: Interventions and Prognosis
2014
Chemotherapy-Induced Cardiotoxicity: Detection, Prevention, and Management
2014
Prevention of Anthracycline-Induced Cardiotoxicity
2014
Role of Drug Metabolism in the Cytotoxicity and Clinical Efficacy of Anthracyclines
2015
Cancer Therapy–Induced Cardiac Toxicity in Early Breast Cancer
2012
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
2005 Standout
Multidrug resistance protein attenuates gemtuzumab ozogamicin–induced cytotoxicity in acute myeloid leukemia cells
2003
Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy
2020 Standout
Myeloid-Derived Suppressor Cells and Mesenchymal Stem/Stromal Cells in Myeloid Malignancies
2021
Inhibition of WNT signaling in the bone marrow niche prevents the development of MDS in the Apcdel/+ MDS mouse model
2017
Anthraquinones As Pharmacological Tools and Drugs
2016 Standout
Works of Athanasios Galanopoulos being referenced
Impaired Proliferative Potential of Bone Marrow Mesenchymal Stromal Cells in Patients with Myelodysplastic Syndromes Is Associated with Abnormal WNT Signaling Pathway
2014
Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia
2002
Cardioprotective effect of metoprolol and enalapril in doxorubicin‐treated lymphoma patients: A prospective, parallel‐group, randomized, controlled study with 36‐month follow‐up
2010